Depas and blood creatine phosphokinase mb increased Patient Reports February 12, 2012

Depas Side Effects Report #5055978-2
Depas side effect was reported by a Physician from JAPAN on July 14, 2006. Male patient, 60 years of age, was treated with Depas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, cardiac failure congestive, dysstasia, dysuria, gamma-glutamyltransferase abnormal, hepatitis fulminant. Depas dosage: unknown. During the same period patient was treated with LENDORMIN, MYSLEE, LOCHOL, ACINON, OLMETEC, CALBLOCK, FERROMIA, EBASTEL. Patient was hospitalized. Patient recovered.

Depas Side Effects Report #5078921-9
Depas side effect was reported by a Physician from JAPAN on July 14, 2006. Male patient, 60 years of age, was treated with Depas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, cardiac failure congestive, dysstasia, dysuria, gamma-glutamyltransferase abnormal, hepatitis fulminant. Depas dosage: unknown. During the same period patient was treated with LENDORMIN, MYSLEE, LOCHOL, ACINON, OLMETEC, CALBLOCK, FERROMIA, EBASTEL. Patient was hospitalized. Patient recovered.